English
Divi's Laboratories Q4 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
6,005.80
-135.45 (-2.21%)
-135.45 (-2.21%)Volume6.62 K
Updated: Tue 20 Jan, 2026 | 15:29:45
NSE
6,013-127.00 (-2.07%)
-127.00 (-2.07%)Volume2.04 L
Updated: Tue 20 Jan, 2026 | 15:40:28
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Divi's Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,806.00 | 1,675.00 | 7.82% | 1,665.00 | 8.47% |
| Depreciation/ Amortization | 107.00 | 99.00 | 8.08% | 95.00 | 12.63% |
| Operating Income | 779.00 | 644.00 | 20.96% | 638.00 | 22.10% |
| Net Income | 662.00 | 589.00 | 12.39% | 538.00 | 23.05% |
| Other Operating Expenses Total | 368.00 | 357.00 | 3.08% | 371.00 | -0.81% |
| Net Income Before Taxes | 864.00 | 726.00 | 19.01% | 713.00 | 21.18% |
| Total Revenue | 2,585.00 | 2,319.00 | 11.47% | 2,303.00 | 12.24% |
| Selling/ General/ Admin Expenses Total | 350.00 | 297.00 | 17.85% | 297.00 | 17.85% |
| Diluted Normalized EPS | 24.93 | 22.20 | 12.31% | 20.24 | 23.17% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.